Anupam Rasayan India Launches Open Offer for Bliss GVS Pharma Limited Shareholders
Anupam Rasayan India Limited has initiated a mandatory Open Offer for the public shareholders of Bliss GVS Pharma Limited. The offer, announced on May 23, 2026, is triggered by the proposed acquisition of a substantial stake in the Target Company by the Acquirer.The Open Offer is designed to acquire up to 2,77,26,848 fully paid-up equity shares of Bliss GVS Pharma Limited, representing 26.00% of the Expanded Voting Share Capital. The Open Offer is being made at a fixed price of ₹ 299.00 per Offer Share. Assuming full acceptance, the total consideration payable by the Acquirer would amount to up to ₹ 8,29,03,27,552.00.The acquisition mandate stems from...